Not reported
Active10067504Private limited companyCambridge
POLYPHARMAKOS LIMITED
Significant control: Adam Reginald Kelliher (25–50%), Lee Richard Harle (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Polypharmakos Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
POLYPHARMAKOS LIMITED is an active private limited company (company number 10067504) incorporated on 16 March 2016, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
There are 196 companies in research and experimental development on biotechnology in Cambridge with filed accounts; the median reports net assets of £15k and is 7 years old.
02
Ownership and control
- Mr Adam Reginald Kelliher
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Lee Richard Harle
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 March 201610 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 30 March 2027in 158 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | — | — | — | £74k | — | — | 0 |
| 31 March 2024 | — | — | — | £11k | — | — | 0 |
Current ratio4.63Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.63
- Incorporated five or more years agoIncorporated 16 March 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 158 days
- Next accounts duein 69 days
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in Cambridge
- MBZ CONSULTING LIMITEDCambridge · inc. Mar 2016
- FIVE ALARM BIO LIMITEDCambridge · inc. Mar 2016
- PROTAVIO LTDCambridge · inc. Feb 2016
- MOGRIFY LIMITEDCambridge · inc. Feb 2016
- STEMNOVATE LIMITEDCambridge · inc. Apr 2016
- CAMENA BIOSCIENCE LIMITEDSaffron Walden · inc. Jan 2016
All companies incorporated on 16 March 2016 · in Mar 2016.
09
Reminders for POLYPHARMAKOS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.